Anixa Biosciences, Inc. (ANIX)
Anixa Biosciences, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Anixa Biosciences, Inc. (ANIX) is a Biotechnology company based in US with a market capitalization of $125.9M. Free cash flow was negative at -$7.2M. This page tracks ANIX's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 5 employees · IPO Oct 7, 1983
Valuation
Valuation & price
$2.82as of May 17, 2026· -46.0% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
8.30
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$125.9M
Market cap
—
Revenue growth (YoY)
23.3%
Gross margin
-$7.2M
Free cash flow (USD)
-$15M
Net debt
Net cash position
1.7%
Share dilution
1/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2023
Value screen
Graham defensive-investor tests
6
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last reported: Jun 10, 2026 (EPS $-0.07)
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- Insider buyJul 21, 2026Filing
Insider Buy $17KKUMAR AMIT · Director, Chief Executive Officer · $17.3K
- Insider buyJul 20, 2026Filing
Insider Buy $42KTitterton Lewis H jr · Director · $41.6K
- Insider buyJul 16, 2026Filing
Insider Buy $9KTitterton Lewis H jr · Director · $9.2K
- Insider buyJul 13, 2026Filing
Insider Buy $15KKUMAR AMIT · Director, Chief Executive Officer · $15.2K
- Insider buyJun 17, 2026Filing
Insider Buy $7KTitterton Lewis H jr · Director · $7.5K
- Insider buyJun 16, 2026Filing
Insider Buy $52KKUMAR AMIT · Director, Chief Executive Officer · $52.5K
- Quarterly reportJun 10, 2026Filing
10-Q Filed
Questions
Frequently asked questions
What is Anixa Biosciences, Inc.'s market cap?
Anixa Biosciences, Inc. (ANIX) has a market capitalization of $125.9M.
What is ANIX's P/E ratio?
A meaningful P/E ratio is not available for ANIX — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is ANIX's price-to-book (P/B) ratio?
ANIX trades at 8.30 times book value per share.
When did Anixa Biosciences, Inc. last report earnings?
ANIX last reported earnings on June 10, 2026; the next date is not yet scheduled.
Are insiders buying ANIX stock?
Yes — SEC Form 4 filings show 6 open-market insider buys and 0 sells at Anixa Biosciences, Inc. in the last 90 days.
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.